Zhirong Wang

Zhangjiagang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Retraction: Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway.

Retraction: Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway.

Journal: Oncotarget

Published: January 21, 2025

The Dopamine D1 Receptor Attenuates Titanium Particle-Induced Inhibition of Osteogenesis by Activating the Wnt Signaling Pathway.

The Dopamine D1 Receptor Attenuates Titanium Particle-Induced Inhibition of Osteogenesis by Activating the Wnt Signaling Pathway.

Journal: Mediators of inflammation

Published: October 04, 2022

Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway.

Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-κB signaling pathway.

Journal: Journal of cellular and molecular medicine

Published: May 01, 2020

Vildagliptin reduced extracellular matrix degradation in human primary chondrocytes.

Vildagliptin reduced extracellular matrix degradation in human primary chondrocytes.

Journal: European journal of pharmacology

Published: July 24, 2018

Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.

Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.

Journal: Acta biomaterialia

Published: April 10, 2017

Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway.

Lithium chloride inhibits titanium particle-induced osteoclastogenesis by inhibiting the NF-κB pathway.

Journal: Oncotarget

Published: March 22, 2017

Titanium particle-induced osteogenic inhibition and bone destruction are mediated by the GSK-3β/β-catenin signal pathway.

Titanium particle-induced osteogenic inhibition and bone destruction are mediated by the GSK-3β/β-catenin signal pathway.

Journal: Cell death & disease

Published: March 06, 2017

Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.

Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.

Journal: Acta biomaterialia

Published: September 19, 2016

Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway.

Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway.

Journal: Scientific reports

Published: August 15, 2016

Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.

Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.

Journal: Acta biomaterialia

Published: August 08, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026